Tag Archives: NASDAQ:ESRX

Healthcare Stocks News Buzz: Herbalife (NYSE:HLF), Express Scripts (NASDAQ:ESRX) – HLF, ESRX, MRK, DCTH, GALE, THC

Posted on April 30, 2013 by Thomas Vedder

Investors responded positively to the healthcare stocks on Monday. Key movement were monitored in Delcath Systems, Inc (NASDAQ:DCTH) on percentage decliners while Galena Biopharma Inc (NASDAQ:GALE) and Tenet Healthcare Corp (NYSE:THC) were prominent stock on percentage gainers side.

Herbalife Ltd …

Posted in Healthcare, Latest Headlines | Tagged DCTH, Delcath, ESRX, Express Scripts, GALE, Galena Biopharma, Herbalife, HLF, Merck, MRK, NASDAQ:DCTH, NASDAQ:ESRX, NASDAQ:GALE, NYSE:HLF, NYSE:MRK, NYSE:THC, Tenet Healthcare, THC | Comments Off

Express Scripts (NASDAQ:ESRX) Post Higher Profit in Fiscal Fourth Quarter on Medco Health Acquisition

Posted on February 19, 2013 by Thomas Vedder

Express Scripts Holding Company (NASDAQ:ESRX) reported on Monday that its profit in fiscal Q4 moved up 74% from previous year, as revenue hiked assisted by purchase of competitor Medco health Solutions Inc in April 2012.

Pharmacy benefits manager’s quarterly EPS …

Posted in Healthcare, Main Post | Tagged ABC, AmerisourceBergen, Catamaran, CTRX, ESRX, Express Scripts Holding, NASDAQ:CTRX, NASDAQ:ESRX, NYSE:ABC, NYSE:UNH, UNH, UnitedHealth | Comments Off

Pfizer Inc., (NYSE:PFE) Lowering Sales Force, Working on New Drugs – PFE, MRK, NVS, SQNM, HEB, ARNA, ONTY, MYL, ESRX

Posted on December 19, 2012 by Thomas Vedder

Pfizer Inc., (NYSE:PFE) the New York health-care specialized firm, would lower almost a fifth of its 3,000-member sales force for primary-care pharmaceuticals as an element of an ongoing cost-lowering attempt, a person closely related with the issue informed Bloomberg News. …

Posted in Healthcare, Latest Headlines | Tagged arena, ARNA, ESRX, Express Scripts, HEB, Hemispherx BioPharma, Merck, MRK, MYL, Mylan, NASDAQ:ARNA, NASDAQ:ESRX, NASDAQ:MYL, NASDAQ:ONTY, NASDAQ:SQNM, Novartis, NVS, NYSE:MRK, NYSE:NVS, NYSE:PFE, NYSEAMEX:HEB, Oncothyreon, ONTY, PFE, Pfizer, Sequenom, SQNM | Comments Off

CVS Caremark Corp. (NYSE:CVS) Hikes Dividend, Plans for Stock Repurchase – CVS, ESRX, WAG, SIRI, DAL, MGM, WAG, MPEL, SWY

Posted on December 13, 2012 by Thomas Vedder

CVS Caremark Corp. (NYSE:CVS)reported on Thursday that it would hike its quarterly dividend by 38%, to 22.5 cent per share, to be paid on Feb. 4 to stock owners of record on or after Jan. 24.

The hike in dividend …

Posted in Latest Headlines, Services | Tagged CVS, CVS Caremark, DAL, Delta Air Lines, ESRX, Express Scripts, Melco Crown Entertainment, MGM, MGM Resorts, MPEL, NASDAQ:ESRX, NASDAQ:MPEL, NASDAQ:SIRI, NYSE:CVS, NYSE:DAL, NYSE:MGM, NYSE:SWY, NYSE:WAG, Safeway, SIRI, Sirius XM Radio, SWY, WAG, Walgreen, Walgreenl | Comments Off

GlaxoSmithKline (NYSE:GSK) Plans to Buy Additional Stock in Indian Unit – GSK, MRK, NVS, SRPT, CTIC, SQNM, ESRX, STJ, GILD

Posted on November 26, 2012 by Thomas Vedder

GlaxoSmithKline PLC (NYSE:GSK)has shown interest in purchasing a further stake of almost 31.8% in its Indian division, GlaxoSmithKline Consumer Healthcare Ltd. , at 3,900 rupees ($70.3) a share, the UK-located firm stated in a report on Monday.

The proposal is …

Posted in Healthcare, Latest Headlines | Tagged Cell Therapeutics, CTIC, ESRX, Express Scripts, GILD, Gilead Sciences, GlaxoSmithKline, GSK, Jude Medical, Merck, MRK, NASDAQ:CTIC, NASDAQ:ESRX, NASDAQ:GILD, NASDAQ:SQNM, NASDAQ:SRPT, Novartis, NVS, NYSE:GSK, NYSE:MRK, NYSE:NVS, NYSE:STJ, Sarepta Therapeutics, Sequenom, SQNM, SRPT, STJ | Comments Off

CVS Caremark Corp. (NYSE:CVS) Gets Outperform Rating – CVS, WAG, ESRX, ODP, NWSA, SPLS, CMCSA, CVC, DISCA

Posted on November 6, 2012 by Thomas Vedder

On Tuesday,Experts at William Blair reiterated their outperform rating on CVS Caremark Corp. (NYSE:CVS)following the firm’s revised third-quarter earnings of 85 cents per share topped their forecast of 83 cents per share.

Experts lifted their fiscal 2012 profit target for …

Posted in Latest Headlines, Services | Tagged Cablevision Systems, CMCSA, Comcast, CVC, CVS, CVS Caremark, DISCA, Discovery Communications, ESRX, Express Scripts, NASDAQ:CMCSA, NASDAQ:DISCA, NASDAQ:ESRX, NASDAQ:NWSA, NASDAQ:SPLS, news, NWSA, NYSE:CVC, NYSE:CVS, NYSE:ODP, NYSE:WAG, ODP, Office Depot, SPLS, Staples, WAG, Walgreen | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.